Gaillard, S., Cantillo, E., Cibula, D., Clamp, A. R., Crafton, S., Denys, H., Finkelstein, K., Gil-Martin, M., Hanker, L. C., Hasegawa, K., Saux, O. L., Monk, B. J., Musa, F., Randall, L., Salutari, V., Slomovitz, B. M., Xiang, Y., Verma, D., Varga, A., Concin, N. (2026). Puxitatug samrotecan (AZD8205) vs chemotherapy in patients with B7-H4–selected advanced/metastatic endometrial cancer: The phase 3 randomized Bluestar-Endometrial01 (BE01)/GOG-3110/ENGOT-EN28 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5647